Anti-CD20 Therapy for Multiple Sclerosis: A Promising Therapeutic Prospect
10th February 2020
Anti-CD20 Therapy for Multiple Sclerosis: A Promising Therapeutic Prospect
The following study was conducted by Scientists from University of California, San Francisco; Johns Hopkins…
